M. Ejtehadifar, S. Zahedi, G. Mosayebi, Ghasem Ghalamfarsa, A. Pishdadian, A. Ghazavi, M. Ebrahimi, A. Ganji
{"title":"IL-27:自身免疫性疾病的朋友或敌人","authors":"M. Ejtehadifar, S. Zahedi, G. Mosayebi, Ghasem Ghalamfarsa, A. Pishdadian, A. Ghazavi, M. Ebrahimi, A. Ganji","doi":"10.2174/1573395513666170707145008","DOIUrl":null,"url":null,"abstract":"Abstract: \n \nBackground: Autoimmune diseases, with emerging clinical concerns, are caused by imbalances in immune system functions. Cytokines are critical components of the immune system produced by various immune and non-immune cells. Objective: We will review the newly-introduced cytokine known as interleukin-27 (IL-27), which has both pro- and anti- inflammatory roles in immunity. Methods: Literature review of the field of immunology and cytokines in autoimmune diseases. Results: IL-27 alters the balance between the different types of T helper (Th) cells through reduction or promotion of their responses to autoimmune diseases including multiple sclerosis, ulcerative colitis, inflammatory bowel disease, rheumatoid arthritis, psoriasis, autoimmune diabetes, systemic lupus erythematosus, Sjogren's syndrome, Behcet’s disease, and autoimmune aplastic anemia. Conclusions: The functions of IL-27 are currently unclear because it appears to affect different cells, cytokines, and signaling pathways differently. Further investigations are needed to clarify the role of IL-27 in autoimmune diseases. Hence, this article reviewed the multiple roles of IL-27 in autoimmune diseases and describe the influence of IL-27 on the immune system.","PeriodicalId":35403,"journal":{"name":"Current Immunology Reviews","volume":"13 1","pages":"163-170"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"IL-27: Friend or Foe in the Autoimmune Diseases\",\"authors\":\"M. Ejtehadifar, S. Zahedi, G. Mosayebi, Ghasem Ghalamfarsa, A. Pishdadian, A. Ghazavi, M. Ebrahimi, A. Ganji\",\"doi\":\"10.2174/1573395513666170707145008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract: \\n \\nBackground: Autoimmune diseases, with emerging clinical concerns, are caused by imbalances in immune system functions. Cytokines are critical components of the immune system produced by various immune and non-immune cells. Objective: We will review the newly-introduced cytokine known as interleukin-27 (IL-27), which has both pro- and anti- inflammatory roles in immunity. Methods: Literature review of the field of immunology and cytokines in autoimmune diseases. Results: IL-27 alters the balance between the different types of T helper (Th) cells through reduction or promotion of their responses to autoimmune diseases including multiple sclerosis, ulcerative colitis, inflammatory bowel disease, rheumatoid arthritis, psoriasis, autoimmune diabetes, systemic lupus erythematosus, Sjogren's syndrome, Behcet’s disease, and autoimmune aplastic anemia. Conclusions: The functions of IL-27 are currently unclear because it appears to affect different cells, cytokines, and signaling pathways differently. Further investigations are needed to clarify the role of IL-27 in autoimmune diseases. Hence, this article reviewed the multiple roles of IL-27 in autoimmune diseases and describe the influence of IL-27 on the immune system.\",\"PeriodicalId\":35403,\"journal\":{\"name\":\"Current Immunology Reviews\",\"volume\":\"13 1\",\"pages\":\"163-170\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Immunology Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1573395513666170707145008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Immunology Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573395513666170707145008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Abstract:
Background: Autoimmune diseases, with emerging clinical concerns, are caused by imbalances in immune system functions. Cytokines are critical components of the immune system produced by various immune and non-immune cells. Objective: We will review the newly-introduced cytokine known as interleukin-27 (IL-27), which has both pro- and anti- inflammatory roles in immunity. Methods: Literature review of the field of immunology and cytokines in autoimmune diseases. Results: IL-27 alters the balance between the different types of T helper (Th) cells through reduction or promotion of their responses to autoimmune diseases including multiple sclerosis, ulcerative colitis, inflammatory bowel disease, rheumatoid arthritis, psoriasis, autoimmune diabetes, systemic lupus erythematosus, Sjogren's syndrome, Behcet’s disease, and autoimmune aplastic anemia. Conclusions: The functions of IL-27 are currently unclear because it appears to affect different cells, cytokines, and signaling pathways differently. Further investigations are needed to clarify the role of IL-27 in autoimmune diseases. Hence, this article reviewed the multiple roles of IL-27 in autoimmune diseases and describe the influence of IL-27 on the immune system.
期刊介绍:
Current Immunology Reviews publishes frontier reviews on all the latest advances in clinical immunology. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in clinical immunology.